These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

83 related items for PubMed ID: 1723315

  • 1. Stromal fibroblastic and hematopoietic progenitors in patients with graft-versus-host disease (GVHD).
    Okamoto T, Kanamaru A, Kakishita E, Nagai K.
    Int J Hematol; 1991 Aug; 54(4):299-306. PubMed ID: 1723315
    [Abstract] [Full Text] [Related]

  • 2. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM, Fortuna A, Fogli M, Gherlinzoni F, Rosti G, Catani L, Gozzetti A, Miggiano MC, Tura S.
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [Abstract] [Full Text] [Related]

  • 3. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.
    Lemoli RM, Gulati SC.
    Stem Cells; 1993 Sep; 11(5):435-44. PubMed ID: 7694721
    [Abstract] [Full Text] [Related]

  • 4. Severe hematopoietic alterations in vitro, in bone marrow transplant recipients who develop graft-versus-host disease.
    Martínez-Jaramillo G, Gómez-Morales E, Sánchez-Valle E, Mayani H.
    J Hematother Stem Cell Res; 2001 Jun; 10(3):347-54. PubMed ID: 11454310
    [Abstract] [Full Text] [Related]

  • 5. Effect of chemotherapy for acute myelogenous leukemia on hematopoietic and fibroblast marrow progenitors.
    Carlo-Stella C, Tabilio A, Regazzi E, Garau D, La Tagliata R, Trasarti S, Andrizzi C, Vignetti M, Meloni G.
    Bone Marrow Transplant; 1997 Sep; 20(6):465-71. PubMed ID: 9313879
    [Abstract] [Full Text] [Related]

  • 6. In vitro sensitivity of post-bone marrow transplantation CFU-GM and BFU-E to TNF-alpha and IFN-gamma.
    Papadakis V, Ferguson KF, Heller G, Kernan NA.
    Exp Hematol; 1995 Dec; 23(14):1422-30. PubMed ID: 8542927
    [Abstract] [Full Text] [Related]

  • 7. [Recovery of marrow myeloid progenitors (CFU-GM) after bone marrow transplantation, especially associated with chronic graft-versus-host disease (GVHD)].
    Takatsu H, Hirokawa M, Oshima A, Miura I, Niitsu H, Takahashi T, Yoshida K, Endo Y, Miura AB.
    Rinsho Ketsueki; 1989 Apr; 30(4):460-5. PubMed ID: 2671438
    [Abstract] [Full Text] [Related]

  • 8. Factors influencing the haematological recovery after allogeneic bone marrow transplantation in leukaemia patients treated with methotrexate-containing GVHD prophylaxis: a single-centre experience.
    Hassan HT, Krog C, Stockschläder M, Schleimer B, Zeller W, Krüger W, Erttmann R, Zander AR.
    Anticancer Res; 1997 Apr; 17(1B):589-99. PubMed ID: 9066585
    [Abstract] [Full Text] [Related]

  • 9. Effects of recombinant granulocyte colony-stimulating factor (rG-CSF) and recombinant granulocyte-macrophage colony-stimulating factor (rGM-CSF) on acute radiation hematopoietic injury in mice.
    Tanikawa S, Nakao I, Tsuneoka K, Nara N.
    Exp Hematol; 1989 Sep; 17(8):883-8. PubMed ID: 2475360
    [Abstract] [Full Text] [Related]

  • 10. Decreased production of cytokines after cytomegalovirus infection of marrow-derived stromal cells.
    Lagneaux L, Delforge A, Snoeck R, Stryckmans P, Bron D.
    Exp Hematol; 1994 Jan; 22(1):26-30. PubMed ID: 7506672
    [Abstract] [Full Text] [Related]

  • 11. Measurement of recipient-specific alloreactivity: is GVHD predictable?
    Theobald M, Bunjes D, Nierle T, Arnold R, Heimpel H.
    Bone Marrow Transplant; 1993 Jan; 12 Suppl 3():S18-23. PubMed ID: 8124251
    [Abstract] [Full Text] [Related]

  • 12. Low incidence of severe aGVHD and accelerating hemopoietic reconstitution in allo-BMT using lenograstim stimulated BM cells.
    Ji S, Chen H, Wang H, Ma J, Pan S, Xue M, Zhu L, Liu J, Xiao M, Zhou L.
    Chin Med J (Engl); 2001 Feb; 114(2):191-5. PubMed ID: 11780205
    [Abstract] [Full Text] [Related]

  • 13. Comparison between bone marrow and G-CSF-mobilized peripheral blood allografts undergoing clinical scale CD34+ cell selection.
    Hassan HT, Zeller W, Stockschläder M, Krüger W, Hoffknecht MM, Zander AR.
    Stem Cells; 1996 Jul; 14(4):419-29. PubMed ID: 8843543
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Study of hematopoietic progenitor cells in thalassemia after bone marrow transplantation.
    Tang-naitrisorana Y, Issaragrisil S, Visuthisakchai S, Suvatte V, Piankijakum A.
    Southeast Asian J Trop Med Public Health; 1995 Jul; 26 Suppl 1():291-5. PubMed ID: 8629127
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
    Ringdén O, Labopin M, Gorin NC, Le Blanc K, Rocha V, Gluckman E, Reiffers J, Arcese W, Vossen JM, Jouet JP, Cordonnier C, Frassoni F.
    J Clin Oncol; 2004 Feb 01; 22(3):416-23. PubMed ID: 14691124
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Abnormal T-lymphocyte colonies (CFU-TL) following bone marrow transplantation.
    Mitsuyasu RT, Li SN, Champlin RE, Gale RP.
    Exp Hematol; 1986 Dec 01; 14(11):1049-55. PubMed ID: 3536545
    [Abstract] [Full Text] [Related]

  • 20. Studies of hemopoietic stromal fibroblastic colonies in patients undergoing bone marrow transplantation.
    Da WM, Ma DD, Biggs JC.
    Exp Hematol; 1986 May 01; 14(4):266-70. PubMed ID: 3516714
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.